Perrigo Future Growth
Future criteria checks 3/6
Perrigo is forecast to grow earnings and revenue by 63.8% and 3.4% per annum respectively. EPS is expected to grow by 57.9% per annum. Return on equity is forecast to be 4.9% in 3 years.
Key information
63.8%
Earnings growth rate
57.9%
EPS growth rate
Pharmaceuticals earnings growth | 24.1% |
Revenue growth rate | 3.4% |
Future return on equity | 4.9% |
Analyst coverage | Low |
Last updated | 07 Nov 2024 |
Recent future growth updates
Recent updates
Is Perrigo (NYSE:PRGO) A Risky Investment?
Dec 06Perrigo Company: Great Combination Of Future Growth With A Low Valuation
Nov 19Perrigo (NYSE:PRGO) Has Announced A Dividend Of $0.276
Nov 07Improved Revenues Required Before Perrigo Company plc (NYSE:PRGO) Shares Find Their Feet
Oct 18Perrigo (NYSE:PRGO) Is Due To Pay A Dividend Of $0.276
Aug 21The Play On Perrigo
Aug 16Perrigo (NYSE:PRGO) Has Announced A Dividend Of $0.276
Aug 07Improved Revenues Required Before Perrigo Company plc (NYSE:PRGO) Shares Find Their Feet
Jul 03These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
May 29Benign Growth For Perrigo Company plc (NYSE:PRGO) Underpins Its Share Price
Mar 27These 4 Measures Indicate That Perrigo (NYSE:PRGO) Is Using Debt Extensively
Feb 01The Market Doesn't Like What It Sees From Perrigo Company plc's (NYSE:PRGO) Revenues Yet
Dec 28Perrigo's New Chapter: Its Bold Turnaround Plan Is Worth Buying
Nov 15The Prognosis For Perrigo
Aug 30Perrigo Outlook Healed By Repositioning
Jun 12Perrigo raises dividend by 5% to $0.273/share
Feb 21Perrigo: Still Languishing But Short-Term Trend Offers Encouragement
Jan 18Perrigo Non-GAAP EPS of $0.56 misses by $0.11, revenue of $1.1B misses by $40M, lowers FY adj. EPS guidance
Nov 08Perrigo to invest $170M to expand baby formula manufacturing, buys Nestlé Gateway plant
Nov 01Perrigo Company plc Is Back On Track
Oct 20Perrigo to face FDA AdCom meeting for OTC contraceptive
Sep 12Perrigo responds to 'misleading and inaccurate information' on Zantac claims
Aug 17Perrigo reports Q2 mixed results; raises FY22 organic net sales growth outlook
Aug 09Perrigo declares $0.26 dividend
Aug 02Perrigo: HRA Acquisition To Drive Significant Growth
Jul 20Perrigo unit seeks FDA over-the-counter approval for birth control pill Opill
Jul 11Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,801 | 128 | 513 | 659 | 5 |
12/31/2025 | 4,636 | 73 | 566 | 616 | 5 |
12/31/2024 | 4,436 | -113 | 294 | 329 | 5 |
9/28/2024 | 4,392 | -147 | 157 | 259 | N/A |
6/29/2024 | 4,428 | -114 | 234 | 341 | N/A |
3/30/2024 | 4,556 | 1 | 301 | 385 | N/A |
12/31/2023 | 4,656 | -4 | 324 | 406 | N/A |
9/30/2023 | 4,654 | 11 | 311 | 383 | N/A |
7/1/2023 | 4,630 | -57 | 255 | 317 | N/A |
4/1/2023 | 4,559 | -131 | 152 | 248 | N/A |
12/31/2022 | 4,452 | -131 | 214 | 307 | N/A |
10/1/2022 | 4,401 | -86 | -102 | 16 | N/A |
7/2/2022 | 4,344 | -88 | 162 | 301 | N/A |
4/2/2022 | 4,203 | -135 | 112 | 235 | N/A |
12/31/2021 | 4,139 | -131 | -63 | 156 | N/A |
10/2/2021 | 4,087 | -215 | 128 | 372 | N/A |
7/3/2021 | 4,047 | -135 | -157 | 91 | N/A |
4/3/2021 | 4,015 | -11 | 214 | 465 | N/A |
12/31/2020 | 4,088 | 44 | 435 | 636 | N/A |
9/26/2020 | 4,358 | 77 | 371 | 615 | N/A |
6/27/2020 | 4,546 | 143 | 406 | 692 | N/A |
3/28/2020 | 4,746 | 140 | 136 | 465 | N/A |
12/31/2019 | 3,870 | 159 | 104 | 388 | N/A |
9/28/2019 | 4,710 | 247 | 272 | 493 | N/A |
6/29/2019 | 4,652 | 87 | 307 | 497 | N/A |
3/30/2019 | 4,689 | 114 | 374 | 515 | N/A |
12/31/2018 | 4,732 | 131 | 469 | 593 | N/A |
9/29/2018 | 4,820 | 123 | 505 | 616 | N/A |
6/30/2018 | 4,918 | 235 | N/A | 668 | N/A |
3/31/2018 | 4,969 | 129 | N/A | 677 | N/A |
12/31/2017 | 4,946 | 120 | N/A | 699 | N/A |
9/30/2017 | 4,994 | -1,313 | N/A | 688 | N/A |
7/1/2017 | 5,025 | -2,947 | N/A | 711 | N/A |
4/1/2017 | 5,127 | -3,412 | N/A | 751 | N/A |
12/31/2016 | 5,281 | -4,013 | N/A | 655 | N/A |
10/1/2016 | 5,308 | -2,872 | N/A | 596 | N/A |
7/2/2016 | 5,320 | -1,021 | N/A | 431 | N/A |
4/2/2016 | 5,395 | -509 | N/A | 683 | N/A |
12/31/2015 | 5,015 | -2 | N/A | 764 | N/A |
9/26/2015 | 4,997 | 144 | N/A | 1,139 | N/A |
6/27/2015 | 4,227 | 136 | N/A | 855 | N/A |
3/28/2015 | 4,217 | 203 | N/A | 1,028 | N/A |
12/27/2014 | 4,172 | 347 | N/A | 941 | N/A |
9/27/2014 | 4,079 | 190 | N/A | 790 | N/A |
6/28/2014 | 3,914 | 233 | N/A | 633 | N/A |
3/29/2014 | 3,884 | 192 | N/A | 575 | N/A |
12/28/2013 | 3,800 | 256 | N/A | 545 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PRGO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: PRGO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PRGO is expected to become profitable in the next 3 years.
Revenue vs Market: PRGO's revenue (3.4% per year) is forecast to grow slower than the US market (9.1% per year).
High Growth Revenue: PRGO's revenue (3.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PRGO's Return on Equity is forecast to be low in 3 years time (4.9%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/17 12:05 |
End of Day Share Price | 2024/12/17 00:00 |
Earnings | 2024/09/28 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Perrigo Company plc is covered by 38 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jasper Hellweg | Argus Research Company |
Ishan Majumdar | Baptista Research |
Douglas Tsao | Barclays |